With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- The montages behind the weddings of Agustín Lara May 25, 2022
- Charlene of Monaco is hidden : his message enthusiastic with the prince Albert Jun 4, 2020
- UMU students will regain full presence on October 4 Sep 24, 2021
- Civil Defense adopts preventive measures to reduce Eid accidents Jul 19, 2021
- Megan Fox erupted in anger at her ex, Brian Austin Green, for an image she posted on Instagram Nov 2, 2020
- How to make money on TikTok: the requirements that influencers ask Aug 24, 2021
- Dismembered man near Rouen: The two accused sentenced to 22 and 17 years in prison Nov 19, 2022